Skip to main content

Piermont Valley Acquisition Corp

corporate_fare Company Profile

Piermont Valley Acquisition Corp

CMCAF·OTC·Life Sciences·CIK 0001865248

Piermont Valley Acquisition Corp is a blank check company, also known as a Special Purpose Acquisition Company (SPAC), incorporated in the Cayman Islands. Its primary purpose is to complete a business combination, such as a merger, share exchange, asset acquisition, share purchase, or reorganization, with one or more existing businesses or entities. On May 12, 2021, its prior sponsor acquired 5,750,000 Class B ordinary shares, referred to as Founder Shares, for a total of $25,000, which is approximately $0.004 per share. As of December 31, 2023, the Sponsor collectively held these 5,750,000 Founder Shares. On December 3, 2021, the company completed an initial public offering of 23,000,000 units at $10.00 per unit, generating gross proceeds of $230.0 million before underwriting discounts and expenses. This total included the underwriter's full exercise of an option to purchase an additional 3,000,000 units to cover over-allotments. Each unit consists of one Class A ordinary share and one-half of one redeemable warrant. Each whole warrant allows the holder to purchase one Class A ordinary share at an exercise price of $11.50 per share, subject to adjustment. Only whole warrants can be exercised or traded. Concurrently with the public offering, the company privately sold 10,500,000 warrants to its Sponsor at $1.00 per warrant, each exercisable to purchase one Class A ordinary share for $11.50 per share, subject to adjustment.

Piermont Valley Acquisition Corp (OTC:CMCAF) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 2 items for CMCAF at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-04-20, rated 8/10. Across its 2 most recent items scored 7 or higher, the top rating is 8/10, with 1 rated 8 or above.

Recent high-impact activity:

  • De-SPAC Deal: Piermont Valley to Combine with Tigerless Health, Up to $100M Earnout Planned
  • Piermont Valley Director Brian Coad Resigns from Board

Short Interest & Short Volume

FINRA reported short interest of 12 shares in CMCAF as of the September 15, 2026 settlement, unchanged from the prior period.

Short interest (bi-monthly positions)12 shares as of September 15, 2026
Change vs prior period 0.0%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

$13
52-week range · as of 2026-04-20 $9.89 – $13
Market cap
$77.41M
Volume
268 (0.0× avg)
3-mo avg 21.5K
Live data · 2026-10-03 21:24 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed CMCAF - Latest Insights

CMCAF
Apr 20, 2026, 6:33 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $11.40
Real-time Price: $13.00 info
Change: Low Volume info
Market Cap: $77.408M info
CMCAF
Mar 10, 2026, 9:53 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $11.40
Real-time Price: $13.00 info
Change: Low Volume info
Market Cap: $77.408M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets